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Abstract. (6,7-3H] Estrone (E) and [6,7-3H]estradiol-17ß (~) 
have been synthesized by reduction of 6-dehydroestrone and 
6-dehydroestradiol with tritium gas. Tritiated E and E2 were 
administered by oral gavage to female rats and to male and 
female hamsters on a dose Ievel of about 300 ~glkg (54 
mCilkg). After 8 h, the liver was excised from the rats; liver 
and kidneys were taken from the hamsters. DNA was purified 
either directly from an organ homogenate or via chromatin. 
The radioactivity in the DNA was expressed in the units of the 
Covalent Binding Index, CBI = (~mol chemical bound per mol 
DNA-P)/(mmol chemical administered per kg b.w.). Rat liver 
DNA isolated via chromatin exhibited the very low values of 
0.08 and 0.09 for E and ~. respectively. The respective figures 
in hamster liver were 0.08 and 0.11 in females and 0.21 and 
0.18 in the males. DNA isolated from the kidney revealed a 
detectable radioactivity only in the female, with values of 0.03 
and 0.05 for E and ~. respectively. The values for male 
hamster kidney were < 0.01 for both hormones. The minute 
radioactivity detectable in the DNA samples does not 
represent covalent binding to DNA, however, as indicated by' 
two sets of control experiments. {A) Analysis by HPLC of the 
nucleosides prepared by enzyme digest of liver DNA isolated 
directly or via chromatin did not reveal any consistent peak 
which could have been attributed to a nucleoside-steroid 
adduct. (B) All DNA radioactivity could be due to protein 
contaminations, because the specific activity of chromatin 
protein was determined to be more than 3 ,000 tim es high er 
than of DNA. The high affinity of the hormone to protein was 
also demonstrated by in vitro incubations, where it could be 
shown that the specific activity of DNA and protein was 
essentially proportional to the concentration of radiolabelled 
hormone in the organ homogenate, regardless of whether the 
animal was treated or whether the hormone was added in vitro 
to the homogenate. 
Carcinogens acting by covalent DNA binding can be 
classified according to potency on the basis of the Covalent 
Binding Index. Values of 103-104 have been found for potent, 
102 for moderate, and 1-10 for weak carcinogens. Since 
estrone is moderately carcinogenic for the kidney of the male 
hamster, a CBI of about 100 would be expected. The actually 
measured Iimit of detection of 0.01 places covalent DNA 
binding among the highly unlikely mechanisms of action. 
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Similar considerations can be made for the liver where any true 
covalent DNA binding must be below a Ievel of 0.01. lt is 
concluded that an observable tumor induction by estrone or 
estradiol is unlikely to be due to DNA binding. 
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Introduction 
Although there is no doubt about the importance of steroid 
estrogen hormones in carcinogenesis (IARC 1974, 1979), the 
mechanism of action is under debate. Three possibilities are 
being discussed, (i) a covalent binding of chemically reactive 
metabolites to DNA (Blackbum et al. 1977; Bolt and Kappus 
1974; Jaggi et al. 1978; Pelkonen et al. 1978; Tsibris and 
McGuire 1977), (ii) the generation of DNA-damaging oxygen 
species generated durlog catechol-quinone oxidation processes 
(Cerutti 1978; Mitchell et al. 1982), and (iii) non-genotoxic 
mechanisms involving some aspect of the hormonal activity 
(Cameron et al. 1982; Henderson et al. 1982; Weisburger and 
Williams 1981; Yager and Yager 1980). It is also possible that 
the effect observed is a result of a combination of the various 
single activities, each of which having a different relative 
weight in different target cell types. 
This laboratory has been involved in attempts to quantify 
the covalent DNA binding of various chemical carcinogens 
(Lutz 1979), and a correlation of tumorigenic vs. DNA-binding 
potencies in vivo (Lutz 1982) seems to allow to assess whether 
a given hepato-carcinogenicity in the rat can be based upon 
DNA binding or whether other mechanism are more likely to 
be responsible (Lutz et al. 1982; Sagelsdorff et al. 1983). 
In 1978, we reported on non-extractable radioactivity on 
liver DNA of rats treated with tritiated ethinylestradiol (EE) 
and estrone (E). Although the apparent binding potency was 
as much as 104 times lower than that of aflatoxin B1 the data 
indicated that a minute genotoxicity of these estrogens 
mediated by DNA binding in vivo could not be excluded (Jaggi 
et al. 1978). The experimental techniques available at that time 
did not allow, however, the definite proof of a DNA-hormone 
adduct on such a low Ievel of binding. With semi-preparative 
HPLC methods becoming available, we have taken up this line 
again, essentially in the search for endogenous DNA ,damage. 
We therefore radiosynthesized [3H]estrone (E) and [3H]estra-
diol (~), administered up to 10 mCi [3H] to rats and hamsters 
and purified DNA from livers and kidneys by different 
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procedures known to produce a DNA with varying degrees of 
protein contamination. Enzymatic hydrolysis of the samples to 
deoxyribonucleosides was performed to investigate whether 
the radioactivity which was measurable in all samples could be 
due to a nucleoside-estrogen adduct. 
Materials and methods 
Chemieals and materials. 6-Dehydruestradiol (1,3,5,(10),6-
estratetraen-3,17ß-diol) and 6-dehydroestrone (1,3,5,(10),6-
estratetraen-3-ol,17-one) were purchased from Research 
Plus Steroid, Denville, NJ. Carrier-free tritium gas was 
from The Radiochemical Centre, Amersham, England. 
L-[4,5-3H(N)]Lysine with a specific activity of 74.6 Ci/mmol 
was from New England Nuclear, Boston, MA. Copperoxide 
(wire form) and palladiurnlcoal (10%) catalyst were from 
Fluka, Buchs, Switzerland, and tlc-alu-silicageJ-60 plates with 
concentrating area, were from Merck, Darmstadt, FRG. 
Nonidet P 40 (NP 40) was from BDH Chemicals, Poole, 
England; Hydroxylapatite (HA) DNA-Grade Bio-Gel HTP 
was from Bio Rad, Riebmond CA; Dialysis tubing (Viking 
type 20/32 molecular weight exclusion 12,000-14,000 Daltons) 
was from Union Carbide, Chicago, IL. Deoxyribonuclease I 
(E.C. 3.1.4.5) from bovine pancreas, phosphodiesterase I 
(E.C. 3.1.4.1) from crotalus atrox venom, alkaline phospha-
tase III (E.C. 3.1.3.1) from Escherichia coli, reference 
nucleosides and reference hormones were from Sigma, St. 
Louis, MO. All other chemieals were from Merck, Darmstadt, 
FRG, or from Fluka, Buchs, Switzerland, and were of 
analytical grade. 
Synthesis of [6, 7-3H]estrone (E) and [6,7-3H]estradiol (E2). E 
and ~ were radiosynthesized by reducing a mixture of 
6-dehydroestrone (0.093 mmol) and 6-dehydroestradiol (0.070 
mmol) according to Merrill and Vernice (1970) with 0.149 
mmol carrier-free tritium gas in 2 ml ethyl acetate containing 
31.5 mg 10% Pd/C catalyst in a 10 ml round-bottom flask for 
2 h at zoo C on a high vacuum line. The remaining educt was 
reduced with hydrogen gas, the unreacted tritium/hydrogen 
mixture was combusted over copper oxide at about 500° C and 
lyophilized into a break-seal ampoule. The reaction yielded 
25.2 mg (0.093 mmol) E and 19.0 mg (0.070 mmol) E2, with a 
specific activity of 48 Ci/mmol. ldentity was checked by 
thin-layer-chromatography and by cocristallization with unla-
belled hormones. Immediately before use, the radiolabelled 
hormones were purified by 2-dimensional thin-layer-chroma-
tography on silica gel with dichloromethane : ethanol 
(100: 7.5) used for the first dimension. The RF values were 
J.57 and 0.43 for E and E2 , respectively. The appropiate strips 
were cut out and developed with ethanol (RF = 1.0 for both 
hormones). The hormones were eluted from the spots with 
~thanol and stored overnight at 4° C. The radiochemical purity 
was determined 1 h before administration to the animals and 
was always better than 98%. 
Animals and treatments. Male and female golden Syrian 
:1amsters [Kfm-Ham/s] (90-120 g) were from Madörin 
Kleintierfarm, Füllinsdorf, Switzerland; Sprague Dawley rats 
flva: SIV 50.SD] (200-250 g) from Ivanovas, Kisslegg im 
Allgäu, FRG. The anima1s bad free access to tap water and 
laboratory chow (No. 21-343-7 Klingental Mühle AG, Basel, 
:iwitzerland). E and Ez was administered by oral gavage in 
about 200 ~1 ethanol on dose Ievels given in the Tables. Urine 
was collected and frozen at -20° C. Eight hours later, the 
animals were killed by open heart puncture under ether 
anaesthesia, and liver and kidneys were excised. 
Isolation of DNA. DNA was isolated in two ways: (a) directly 
from a Ii ver homogenate blended under denaturing conditions 
in lysing medium (0.24 M sodium phosphate, 8 M urea, 0.01 M 
EDTA, 1% sodium dodecylsulfate (SDS), pH 6.8, (Viviani 
and Lutz 1978), (b) via chromatin which was prepared by 
homogenizing the liver in three volumes 75 mM NaCl, 10 mM 
EDTA, 10 mM Tris/HCI pH 7.8 in a Potter-Elvehjem-type 
teflon homogenizer and precipitation with the non-ionic 
detergent NP 40.according to Yaneva and Dessev (1976). This 
pellet contained about 2-3 mg DNA and 20-30 mg protein 
pergram liverandwas blended in lysing medium. The further 
purification of the DNA from a) and b) followed the standard 
method used in our laboratory (Sagelsdorff et al. 1983) which is 
based on a deproteination with phenol : chloroform : isoamyl 
alcohol (PCI) and extensive washing after adsorption to a 
hydroxylapatite · column. After desorption with high ionic 
strength (0.48 M in phosphate) and dialysis against 0.2 M 
sodium chloride, DNA was precipitated with two volumes of 
ethanol, stored overnight at -200 C, dried on aspirator 
vacuum and dissolved in 10 mM MgCI2, 10 mM Tris buffer pH 
7.0. The amount of DNA was determined on the basis of an 
absorbance of 20 for a solution of 1 mg/ml (Viviani and Lutz 
1978). An aliquot of the DNA (0.4-1 mg) was used for liquid 
scintillation counting. 
Isolation of chromatin protein. One milliliter of the first PCI 
extract was shaken with 2 ml 1% SDS in 14 mM sodium 
phosphate pH 6.8. Protein was precipitated with 25 ml 
acetone, redissolved and reprecipitated five times. Finally, the 
protein sample was diluted 1 : 10 with destilled water. 
precipitated with about two volumes of acetone at -20° C, 
redissolved in 2 ml1% SDS, and diluted with water 1: 10. The 
amount of proteinwas determined with the Polin reagent. One 
milliliter (about 0.5 mg protein) was used for liquid scintil-
lation counting. 
Contamination of purified DNA with protein. Two male rats 
(250 g) were given by oral gavage 7 mCi/kg L-[3H)lysine. After 
4 h, DNA and chromatin proteinwas isolated via chromatin 
from the livers. The specific protein activity was 44,100 and 
45,200 dpm/mg and the DNA was radiolabelled to give 95.4 
and 108 dpm/mg. Nucleoside analysis showed that the natural 
nucleosides were not radiolabelled. 
HPLC analysis of the nucleosides. DNA (1-2 mglml) was 
digested enzymatically by the method described (Sagelsdorff et 
al. 1983). The deoxynucleosides were separated by HPLC with 
a water to methanol gradient (0-10% in 5 min, 10% for 5 min, 
10-100% in 40 min) using a HPLC system consisting of a 
semipreparative column (250 mm · 8 mm ID) Lichrosorb RP 
18 equipped with two HPLC pumps (Kontron LC pump 410) 
controlled by a Kontron programmer 200, for generating a 
linear gradient of two eluants (Kontron, Zürich, Switzerland). 
Fractions of 2 min (7 ml) were collected and counted for 
radioactivity after addition of about 1 ml MeOH to the 
fractions no. 12-15 to avoid phase Separationafteraddition of 
Insta-Gel. 
HPLC of estrogen metabolites. The supernatant of the first 
acetone precipitation of chromatin protein from the PCI phase 
was dried under a stream of nitrogen and dissolved in the same 
buffer used for DNA. Urine samples were diluted with 
DNA-buffer to a specific activity of about 1,000 dpm/ml. 
Reference hormone samples estrone, estradiol, estriol were 
dissolved in the same buffer. All samples were analyzed by the 
HPLC system used for the separation of nucleosides. 
Control experiments. No. 1. Binding of radiolabelled metabo-
lites to DNA occuring only during the isolation procedure was 
checked by incubating the supernatant of the first chromatin 
precipitation ( derived from rat No. 3 and 6) with an unlabelled 
chromatin pellet from a control rat. DNA was then isolated 
according to method b). 
No. 2. Non-enzymatic binding of [3H]estrone to DNA was 
checked by incubating for 2 h at room temperature 1 mCi 
hormone with a homogenate of 4 g liver prepared (i) by 
blending in 25 ml lysing medium and (ii) by the homogeni-
zation in 20 ml as used for chromatin precipitation. DNA was 
isolated (i) directly and (ii) via chromatin, and exhibited a 
specific activity of 900 and 40 dpm/mg, respectively. The 
former value was about one hundred times higher than the 
value reported by Jaggi et al. (1978) from a similar control 
experiment. 
Background radioactivity of DNA and of nucleoside 
fractions was deterrnined from samples obtained from animals 
which were held in parallel to the treated ones and which did 
not receive radiolabelled compounds. 
Liquid scintillation counting, calculations and statistics. Sam-
pies were counted in Packard high performance glass vials in a 
Packard Tri Carb 460 CD liquid scintillation counter in 10 ml 
Insta-Gel (Packard Instruments, Downers Grove, IL). 
The specific radioactivity of DNA was normalized by the 
radioactivity dose administered: 
CBI' = (dpm/mg DNA)/(dpm/kg body weight). 
This value was converted to molar units of the Co valent Binding 
Index CBI (J.tmol chemical bound/mol DNA-P)/ 
(mmol chemical applied/kg b.w.) (Lutz 1979), by multiplica-
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tion of the CBI' with 309 · 106 on the basis of an average 
molecular weight of 309 for a deoxyribonucleotide in 
DNA. 
The Iimit of detection for radioactivity in a DNA sample 
was calculated on the Ievel of two standard deviations (SD). 
One SD was determined to be 0.5 cpm as derived from the 
standard deviation determined within each of 16 pairs of 
background counts of DNA isolated from untreated animals 
(Kaiser 1965). 
The Iimit of detection for radioactivity in a nucleoside 
analysis was calculated on the basis of the total variability due 
to statistical counting error and fluctuations due to vial, 
scintillation cocktail, counter, external radiation and compo-
sition of the sample of each fraction as compiled from five 
nucleoside analyses of control DNA digests and is shown in the 
Figures on a Ievel of ·two SD as a shaded area. 
Results 
Experiments with female rats 
Table 1 summarizes the results obtained for the radioactivity in 
liver DNA and chromatin protein, 8 h after oral administration 
of tritiated estrogen hormones to female rats. All liver DNA 
samples were radiolabelled to an extent which can be called 
minimal if it is considered that each animal received of the 
order of 10 mCi of [3H]radiolabel. No difference between B-
and Ertreatment was observable, the mean values for the 
activity of DNA isolated via chromatin, and expressed after 
normalization by the dose administered in CBI units, being 
0.082 ± 0.033 and 0.086 ± 0.014 for E and ~, respectively. 
These values were by a factor of 13 lower than the values 
published earlier (Jaggi et al. 1978) obtained after direct 
isolation of DNA from Ii ver homogenate. One main difference 
between the two isolation procedures is the Ievel of protein 
contamination. The direct DNA isolation as used in the early 
stUdy yielded a protein contamination of0.5% as derived from 
experiments with (35S]methionine incorporated into protein 
(Lutz 1979). DNA isolated via chromatin and use of [lH]lysine 
as a protein precursor resulted in a value of about 0.2%. 
Table 1. Binding of tritium radioactivity to liver DNA of female rats, 8 h after oral administration of [3H]estrone and [3H]estradiol 
Hormone Estrone Estrone Estrone Estrone Estradiol Estradiol Estradiol Estradiol 
Animal no.lbody 1/204 2/211 3/205 Control 4/203 5/204 6/223 Control 
weight (g) exp. no. 1 exp. no. 1 
Dose 
J!g/kg 303 324 475 277 270 492 
mCilkg 54 58 84 49 48 87 
Organ Li ver Li ver Li ver Chromatin Li ver Li ver Li ver Chromatin 
[lH] Activity 3.7 3.0 3.0 Supemat. of 2.3 2.6 2.6 Supernat. of 
(% of dose) rat no. 3 rat no. 6 
DNA 
Method of isolation Chrom. Direct Chrom. Direct Chrom. Chrom. Chrom. Chrom. Chrom. Chrom. 
Total act. (cpm) 19.2 25.3 19.7 35.9 44.5 27.5 19.8 22.3. 40.3 34.1 
Background (cpm) 14.7 14.7 14.7 14.7 20.9 20.3 14.7 14.7 20.9 20.3 
Spec. act. ( dpm/mg) 23.0 59.3 27.3 109.()3 72.43 39.2 24.5 31.5 59.0 52.5 
CBI units 0.06 0.15 0.07 0.26 0.12 0.07 0.09 0.10 
Chromatin protein 
Specific activity 
(dpm/mg) 6.5 ·HP 5.4 ·HP 2.5. 105 1.9 · lOS 2.7 ·lOS 3.5 ·lOS 1.65 · lOS 1.5 ·lOS 
a An aliquot of this DNA sample was used for an HPLC analysis of deoxynucleosides (see Fig. 1) 
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Taking into account the relative abundance of methionine or 
Iysine in a protein fraction likely to become a contaminant of 
DNA, a difference by factors of2-3 (Table 1) and 13 (early vs. 
present study) are indeed of the same order. 
Because it is assumed that steroid estrogen hormones exert 
their hormonal activity on the DNA Ievel via protein receptor 
binding (Brotherton 1976), the protein activity could be very 
high and the protein contamination of DNA could become 
crucial. The determination of the specific activity of chromatin 
protein (Table 1, bottom line) shows that this is the case. 
Specific activities were 3 · 1()3 to 3 · 104 times higher in protein 
than in DNA. DNA radioactivities are therefore most 
probably due to traces of contaminating protein, and the 
higher apparent CBI values obtained via direct DNA isolation 
(Jaggi et al. 1978; and data given in Table 1) are easily 
unterstood. Although the protein contamination is reason 
enough to explain the DNA radioactivity, DNA aliquots were 
digested enzymatically to nucleosides, and the nucleosides 
were analyzed by HPLC in a search for potential nucleo-
side-estrone metabolite adducts (Fig. 1). Both DNA isolated 
directly and via chromatin were analysed. The distribution of 
radioactivity over the elution profile was completely different 
except for fractions 2 and 5 + 6 which were radiolabelled in 
both samples. A nucleoside-steroid adduct expected to be 
more lipophilic than the natural nucleosides and to elute in 
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Fig. 1. Optical density (top) and radioactivity profile (center and 
bottom) of HPLC analyses of DNA samples isolated directly (center) 
or via chromatin (bottom) from the liver of female rats, 8 h afteroral 
administration of [6,7-3H]estrone. dC, dG, T, dA = natural deoxy-
ribonucleosides. E, Ez, E3 = elution area for estrone, estradiol and 
estriol. Center: Enzymedigest of 2.1 mg DNA loaded, containing 229 
dpm; [lH]recovery 88%. Bottom: 2.5 mg DNA containing 180 dpm; 
[lH]recovery 109% 
later fractions could not therefore be located. The radioactivity 
did not either coelute with the natural nucleosides. This is an 
indication that no incorporation of tritium from tritiated water 
or other small radiolabelled breakdown products into DNA 
bad occurred during biosynthesis. The DNA radioactivity must 
therefore rather be due to contaminations by metabolites 
and/or contaminating protein present in a qualitatively differ-
ent way dependent on the method of DNA isolation. 
In order to verify that radioactivity eluting in fractions 
2 and 5 + 6 could be due to metabolites, the organic extract 
(PCI phase) of chromatin and a diluted urine sample were 
loaded on the HPLC system. Figure 2 with the respective 
elution profiles shows that both samples contained radiola-
belled material eluting in these early fractions. 
Control incubations. If the DNA radioactivity is primarily a 
function of proteinnot completely removed from the DNA, 
such a non-covalent interaction should also be formed if an 
unlabelled control chromatin pellet is resuspended in the 
radioactive supernatant of a chromatin precipitation obtained 
in a main experiment. The results of this control experiment 
no. 1 given in Table 1 show that the specific activity of DNA 
and chromatin protein isolated from the unlabelled control 
pellet was almost as high as the macromolecules derived from 
the animals which bad been administered E or E2• The specific 
activity of the control protein was so high after this in vitro 
incubation that as little as 0.03% contamihation on the DNA 
could fully account for the radioactivity measured in the 
DNA. 
Control experiment no. 2 substantiated the hypothesis that 
the difference between the specific activity of DNA samples 
obtained by different isolation procedures is due to different 
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Fig. 2. Radioactivity profile (center and bottom) of HPLC analyses of 
the organic extract (with PCI) obtained during the isolation of DNA 
from chromatin (center) and of urine collected from an E-treated 
female rat. The HPLC systemwas the same as used for the analysis of 
enzyme-digested DNA 
contaminations by non-covalently bound estrogen. There was 
a 20-fold differenc~ in the specific activity ofthe DNA purified 
directly or via chromatin after incubation of liver homogenate 
with [3H]E, the absolute values being equal to or even higher 
than those found .after treatment of animals if the specific 
activities are adjusted to the same radioactivity Ievels in the 
homogenate. 
Additional control experiments not to be reported in detail 
here have shown that each DNA purification step reduced the 
specific activity only by a certain factor from non-covalently 
bound radioactivity so that, for a given procedure and a given 
compound, the amount of radioactivity present in the 
homogenate ultimately determines the residual DNA radioac-
tivity. 
Experiments with male and female hamsters. The kidney of the 
male (but not the female) hamster is known to be a target 
organ for estrogen carcinogenicity (IARC 1979). If a reactive 
metabolite is formed in the male hamster kidney able to bind to 
DNA in substantial amounts, a difference between males and 
females should be observable. The data· obtained after oral 
administration of E and ~ are compiled in Tables 2 and 3, 
respectively. Similarly to the rat, allliver DNA samples were 
slightly radiolabelled, and there was, again, no difference 
observable between E and ~-
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Among the DNA samples isolated from the kidneys, a 
minnte radioactivity was detectable only in the females. 
Kidney DNA isolated from male hamsters did not contain any 
measurable radioactivity on a Iimit of d~tection of 3.2 dpm per 
scintillation vial. This finding is in contrast to what could have 
happened if the susceptibility of the male to tumor induction 
was reflected by higher DNA binding. The difference between 
males and females does not go in parallel with the radioactivity 
present in the whole kidney homogenate. There, the value for 
the male was two to three times higher than for the fernale. A 
working hypothesis to explain this finding will be given in the 
Discussion section. 
Discussion 
Our findings make it highly unlikely that a genotoxic activity of 
estrone and estradiol mediated by DNA binding is a 
mechanism of tumorigenic activity. The high Ievel of pro-
tein-bound radioactivity can easily explain all radioactivity 
measured on a DNA sample. . 
The high Ievel of protein binding could be achieved by 
non-covalent binding to a specific hormone receptor. This 
protein could in turn bind to specific regions in the DNA 
(Baskevitch et al. 1983; Brotherton 1976) and be the reason for 
the apparent DNA binding of hormones. In addition, covalent 
Tsble 2. Binding of tritium radioactivity to liver and kidney DNA of male and female hamsters, 8 h after oral administration of 
[ 3H]estrone . 
Sex; no. Male 1 Male 2 Fernale 3 Fernale 4 
Body weight (g) 120 120 136 128 
Dose 
~glkg 261 269 347 354 
mCi!kg 46.5 47.9 61.9 63.0 
PHl Activity in total 1.01 1.05 0.50 0.56 
whole blood 
(% of dose) 
Organ Liver Kidney Li ver Kidney Li ver Kidney Li ver Kidney 
PH1 Activity 5.1 0.22 5.6 0.21 1.5 0.08 1.6 0.09 
(% of dose) 
DNA isolated via chromatin 
Total act. (cpm) 29.5 16.8 29.7 17.2 20.9 21.6 25.6 19.8 
Background (cpm) 15.9 16.5 15.4 16.5 15.9 16.5 15.4 16.5 
Spec. act. ( dpmlmg) 69.6 < 3.2 76.5 < 3.2 29.1 13.5 39.5 11.2 
CBI units 0.21 < 0.01 0.22 < 0.009 0.07 0.03 0.09 0.025 
Table 3. Binding of tritium radioactivity to liver and kidney DNA of male and female hamsters, 8 h after oral administration of 
[lH]estradiol 
Sex; no. Male 1 Male 2 Fernale 3 Fernale 4 
Body weight (g) 119 111 143 148 
Dose 
~glkg 289 314 222 213 
mCi/kg 51.2 55.5 39.2 37.6 
Organ Li ver Kidney Li ver Kidney Li ver Kidney Li ver Kidney 
[3H] Activity 6.3 0.26 7.0 0.32 1.8 0.11 2.4 0.13 
(% of dose) 
DNA isolated via chromatin 
Total act. (cpm) 26.7 16.5 28.8 15.8 20.1 19.4 22.6· 20.1 
Background (cpm) 15.9 16.5 15.4 16.5 15.9 16.5 15.4 16.5 
Spec. act. ( dpmlmg) 71.5 < 4.5 69.3 < 3.2 22.7 11.3 38.1 12.4 
CBI units 0.19 < 0.009 0.17 < 0.008 0.08 0.04 0.14 0.05 
1')2 
hteractions with protein cannot be excluded. Estrogen 
t.ormones are to a certain extent oxidized to catechols and 
<:Uinones, compounds which are slightly electrophilic and can 
react with thiol ( -SH) groups of cysteine and its derivates. Fora 
reaction of quinones with DNA, i.e., with centers of much 
lower nucleophilicity, very specific substituents and configu-
rations seem to be required such as those found in certain 
antineoplastic antibiodes of natural origin (Moore 1977). No 
chemical data are, however, available to show a covalent 
interaction of simple benzoquinones with DNA. 
A nurober of ieports deal with the binding of estrogens to 
rrotein and DNA in vitro (Bucala et al. 1982; Kappus et al. 
1973; Kappus and Bolt 1976; Maggs et al. 1982; Marks and 
Hecker 1969; Refs. in the Introduction) in the presence of 
s:>me drug-metabolizing system. The radioactivity isolated 
with these DNA samples can always be attributed to protein 
contaminations because the data are comparable to our in vitro 
control incubations if the specific activity of the macromole-
cules is put into relation to the radioactivity incubated. A more 
extensive purification of the DNA by CsCl gradient for 
instance revealed that the radioactivity did not coelute with the 
optical density of the DNA band (Duncan and Brookes, 
1979). 
Biological test systems for genotoxicity in general pro-
duced negative results, for instance in the Ames test (Lang and 
Redmann 1979), in mutagenicity tests in mammalian cells 
(Drevon et al. 1981), in a DNA repair assay in vitro or alkaline 
elution test in vivo (Yager and Fifield 1982) or in a test on 
initiating capabilities in the Solt-Farber system (Schuppler et 
al. 1983). 
Our data do not exclude a genotoxic mechanism of action 
in general. Evidence is increasing on the importance of oxygen 
udicals in tumor initiation and first stage promotion and it is 
postulated that quinone-hydroquinone oxidation-reduction 
processes can generate reactive oxygen species able to 
hydroxylate DNA. This type of indirect genotoxicity goes 
unobserved ifDNA is investigated for bound radiolabelled test 
c:>mpound and it is conceivable that the oxidation of estrone 
and estradiol to catechol and the corresponding quinone could 
r·~sult in indirect DNA damage. So far, there is no indication 
that this mechanism of action is operative in the liver. Y ager 
and Fifield (1982) did not detect any DNA darnage induced by 
estrogens either in vivo as assessed by alkaHne elution or in 
primary hepatocyte culture as assessed by DNA repair 
synthesis. Nevertpeless, this type of indirect genotoxicity could 
become particularly important in cells which do not have much 
estrogen receptor protein but some drug-metabolizing capac-
ity. This situation could be encountered in the male hamster 
kidney, a target for es trogen carcinogenicity. Possibly because 
estrogens are bound only weakly to protein in this organ in the 
male, we were able to isolate a DNA free of radioactivity 
although the whole-organ radioactivity was even higher than in 
the females where DNA radioactivity was detectable. 
Malignant renal tumors were found in 15 out of 15 male 
hamsters treated with a 20 mg pellet of E2 subcutaneously 
every 21 weeks (IARC 1979). An average estimated dose of as 
little as 5 J.tmol/kg/day as used in this treatment therefore led to 
a 100% tumor incidence. A correlation of tumorigenic 
potencies and CBI for DNA of the target organ (Lutz 1982) 
shows that CBI of > 102 would be required, if covalent binding 
to DNA was the mechanism of carcinogenic action. The actual 
CBI for DNA of the male hainster kidney was < 10-2• The 
discrepancy by a factor of > 104 is an additional indication that 
mechanisms other than DNA binding must be responsible for 
the respective tumor formation. It must therefore be con-
cluded that DNA binding is an unlikely mechanism of 
tumorigenic action of estrone or estradiol. 
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